PFE · Categories · Coverage
PFE - Analyst coverage initiated
Pfizer Inc. (PFE) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for PFE
- RBC Capital Mkts initiated coverage on Pfizer with a new price targetRBC Capital Mkts initiated coverage of Pfizer with a rating of Underperform and set a new price target of $25.00
- Barclays initiated coverage on Pfizer with a new price targetBarclays initiated coverage of Pfizer with a rating of Underweight and set a new price target of $25.00
- Scotiabank initiated coverage on Pfizer with a new price targetScotiabank initiated coverage of Pfizer with a rating of Sector Outperform and set a new price target of $30.00
- Cantor Fitzgerald initiated coverage on Pfizer with a new price targetCantor Fitzgerald initiated coverage of Pfizer with a rating of Neutral and set a new price target of $24.00
- Wolfe Research initiated coverage on Pfizer with a new price targetWolfe Research initiated coverage of Pfizer with a rating of Underperform and set a new price target of $25.00
- Bernstein initiated coverage on Pfizer with a new price targetBernstein initiated coverage of Pfizer with a rating of Mkt Perform and set a new price target of $32.00
- Guggenheim initiated coverage on Pfizer with a new price targetGuggenheim initiated coverage of Pfizer with a rating of Buy and set a new price target of $36.00
- HSBC Securities initiated coverage on Pfizer with a new price targetHSBC Securities initiated coverage of Pfizer with a rating of Buy and set a new price target of $50.00
- Jefferies initiated coverage on Pfizer with a new price targetJefferies initiated coverage of Pfizer with a rating of Hold and set a new price target of $43.00
- Credit Suisse initiated coverage on Pfizer with a new price targetCredit Suisse initiated coverage of Pfizer with a rating of Outperform and set a new price target of $55.00
- SVB Leerink initiated coverage on Pfizer with a new price targetSVB Leerink initiated coverage of Pfizer with a rating of Mkt Perform and set a new price target of $55.00
- Goldman initiated coverage on Pfizer with a new price targetGoldman initiated coverage of Pfizer with a rating of Neutral and set a new price target of $51.00
- Wells Fargo initiated coverage on Pfizer with a new price targetWells Fargo initiated coverage of Pfizer with a rating of Overweight and set a new price target of $60.00
- BMO Capital initiated coverage on Pfizer with a new price targetBMO Capital initiated coverage of Pfizer with a rating of Outperform and set a new price target of $60.00
- The Goldman Sachs Group initiated coverage on Pfizer with a new price targetThe Goldman Sachs Group initiated coverage of Pfizer with a rating of Neutral and set a new price target of $41.00
- The Goldman Sachs Group initiated coverage on Pfizer with a new price targetThe Goldman Sachs Group initiated coverage of Pfizer with a rating of Neutral and set a new price target of $41.00
- JPMorgan Chase & Co. initiated coverage on Pfizer with a new price targetJPMorgan Chase & Co. initiated coverage of Pfizer with a rating of Neutral and set a new price target of $36.00